These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 19149829)

  • 1. Cost-effectiveness of pharmacy and group behavioural support smoking cessation services in Glasgow.
    Boyd KA; Briggs AH
    Addiction; 2009 Feb; 104(2):317-25. PubMed ID: 19149829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-year outcomes and a cost-effectiveness analysis for smokers accessing group-based and pharmacy-led cessation services.
    Bauld L; Boyd KA; Briggs AH; Chesterman J; Ferguson J; Judge K; Hiscock R
    Nicotine Tob Res; 2011 Feb; 13(2):135-45. PubMed ID: 21196451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The English smoking treatment services: one-year outcomes.
    Ferguson J; Bauld L; Chesterman J; Judge K
    Addiction; 2005 Apr; 100 Suppl 2():59-69. PubMed ID: 15755262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Breathe': the stop smoking service for pregnant women in Glasgow.
    McGowan A; Hamilton S; Barnett D; Nsofor M; Proudfoot J; Tappin DM
    Midwifery; 2010 Jun; 26(3):e1-e13. PubMed ID: 18692285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cost-effectiveness analysis of a community pharmacist-based smoking cessation programme in Thailand.
    Thavorn K; Chaiyakunapruk N
    Tob Control; 2008 Jun; 17(3):177-82. PubMed ID: 18285385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost-effectiveness of a smoking cessation program for out-patients in treatment for depression.
    Barnett PG; Wong W; Hall S
    Addiction; 2008 May; 103(5):834-40. PubMed ID: 18412763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The carbon footprint of behavioural support services for smoking cessation.
    Smith AJ; Tennison I; Roberts I; Cairns J; Free C
    Tob Control; 2013 Sep; 22(5):302-7. PubMed ID: 23481905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining the cost-effectiveness of a computer-based smoking cessation intervention in primary care.
    Smith MY; Cromwell J; DePue J; Spring B; Redd W; Unrod M
    Manag Care; 2007 Jul; 16(7):48-55. PubMed ID: 17907712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analyses of health promotion programs: a case study of smoking prevention and cessation among Dutch students.
    Vijgen SM; van Baal PH; Hoogenveen RT; de Wit GA; Feenstra TL
    Health Educ Res; 2008 Apr; 23(2):310-8. PubMed ID: 17675649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One size fits all? A process evaluation--the turn of the 'story' in smoking cessation.
    Ritchie D; Schulz S; Bryce A
    Public Health; 2007 May; 121(5):341-8. PubMed ID: 17292931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the effectiveness of group-based and pharmacy-led smoking cessation treatment in Glasgow.
    Bauld L; Chesterman J; Ferguson J; Judge K
    Addiction; 2009 Feb; 104(2):308-16. PubMed ID: 19149828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness analysis of a European primary-care physician training in smoking cessation counseling.
    Pinget C; Martin E; Wasserfallen JB; Humair JP; Cornuz J
    Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):451-5. PubMed ID: 17568248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Varenicline as compared to bupropion in smoking-cessation therapy--cost-utility results for Sweden 2003.
    Bolin K; Mörk AC; Willers S; Lindgren B
    Respir Med; 2008 May; 102(5):699-710. PubMed ID: 18289839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of proactively identifying smokers and offering smoking cessation support in primary care populations: a cluster-randomized trial.
    Murray RL; Coleman T; Antoniak M; Stocks J; Fergus A; Britton J; Lewis SA
    Addiction; 2008 Jun; 103(6):998-1006; discussion 1007-8. PubMed ID: 18422823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated tobacco-use screening and intervention in clinical practice: health impact and cost effectiveness.
    Solberg LI; Maciosek MV; Edwards NM; Khanchandani HS; Goodman MJ
    Am J Prev Med; 2006 Jul; 31(1):62-71. PubMed ID: 16777544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A survey into smokers' interest in quitting smoking and in the provision of smoking cessation counselling in community pharmacies].
    Vavrík M; Matejka P; Svec P
    Ceska Slov Farm; 2005 Jul; 54(4):178-83. PubMed ID: 16124199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Predictors of smoking cessation in group-based behavioral intervention programme--research findings in 2001-2007].
    Broszkiewicz M; Sobala W; Drygas W
    Przegl Lek; 2008; 65(10):634-40. PubMed ID: 19189567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons from the English smoking treatment services.
    Raw M; McNeill A; Coleman T
    Addiction; 2005 Apr; 100 Suppl 2():84-91. PubMed ID: 15755263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How cost-effective is 'No Smoking Day'?
    Kotz D; Stapleton JA; Owen L; West R
    Tob Control; 2011 Jul; 20(4):302-4. PubMed ID: 20472574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct telemarketing of smoking cessation interventions: will smokers take the call?
    Paul CL; Wiggers J; Daly JB; Green S; Walsh RA; Knight J; Girgis A
    Addiction; 2004 Jul; 99(7):907-13. PubMed ID: 15200586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.